We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
-$748M
Cap. Flow
-$1.54B
Cap. Flow %
-9.38%
Top 10 Hldgs %
4.71%
Holding
4,854
New
668
Increased
1,369
Reduced
1,663
Closed
1,012

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$82.1M
2
HON icon
Honeywell
HON
+$65.3M
3
NSC icon
Norfolk Southern
NSC
+$60.4M
4
SCHW
Charles Schwab
SCHW
+$55.7M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$55.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.1M
2
UAL icon
United Airlines
UAL
+$56.6M
3
CME icon
CME Group
CME
+$50.4M
4
LRCX icon
Lam Research
LRCX
+$47M
5
LUV icon
Southwest Airlines
LUV
+$37.4M

Sector Composition

Rank Sector Weight
1 Technology 11.78%
2 Financials 10.54%
3 Industrials 9.15%
4 Healthcare 9.04%
5 Consumer Discretionary 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTNT icon
3576
CALL
Fortinet
FTNT
$121B
$46.5K ﹤0.01%
700
-14,100
-95% -$802K
ROVR
3577
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$46.2K ﹤0.01%
10,203
-26,366
-72% -$106K
PBI icon
3578
Pitney Bowes
PBI
$2.29B
$45.9K ﹤0.01%
11,802
-20,676
-64% -$86.9K
CCCC icon
3579
C4 Therapeutics
CCCC
$501M
$45.7K ﹤0.01%
14,560
-30,540
-68% -$180K
SOAR.WS
3580
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$45.5K ﹤0.01%
589,696
– –
LCTX icon
3581
Lineage Cell Therapeutics
LCTX
$271M
$45.2K ﹤0.01%
30,155
+5,678
+23% +$7.92K
CDLX icon
3582
Cardlytics
CDLX
$25.7M
$44.5K ﹤0.01%
1,312
-684
-34% -$35.7K
PAYS icon
3583
Paysign
PAYS
$741M
$44.2K ﹤0.01%
+12,189
New +$41.6K
IMGN
3584
DELISTED
Immunogen Inc
IMGN
$43.9K ﹤0.01%
11,435
-246,337
-96% -$1.05M
VMD icon
3585
Viemed Healthcare
VMD
$354M
$43.9K ﹤0.01%
+4,542
New +$39.6K
AMRX icon
3586
Amneal Pharmaceuticals
AMRX
$6.15B
$43.5K ﹤0.01%
31,291
-33,623
-52% -$66.9K
NKTR icon
3587
Nektar Therapeutics
NKTR
$2.58B
$43.2K ﹤0.01%
4,095
-20,318
-83% -$615K
STAG icon
3588
STAG Industrial
STAG
$7.13B
$42.9K ﹤0.01%
1,269
-480
-27% -$16.4K
MORF
3589
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$42.9K ﹤0.01%
1,140
-9,191
-89% -$339K
TRUP icon
3590
Trupanion
TRUP
$1.34B
$42.7K ﹤0.01%
996
-5,726
-85% -$310K
FRMM
3591
Forum Markets
FRMM
$83.1M
$42.3K ﹤0.01%
+124
New +$72.1K
SKYX icon
3592
SKYX Platforms
SKYX
$153M
$42.1K ﹤0.01%
+12,171
New +$40.1K
KODK icon
3593
Kodak
KODK
$988M
$41.9K ﹤0.01%
10,215
-137,231
-93% -$495K
TSVT
3594
DELISTED
2seventy bio
TSVT
$41.9K ﹤0.01%
4,106
+3,694
+897% +$42.2K
HRTX icon
3595
Heron Therapeutics
HRTX
$62.5M
$41.1K ﹤0.01%
27,238
-323,243
-92% -$809K
SCYX icon
3596
SCYNEXIS
SCYX
$49.2M
$40.2K ﹤0.01%
+1,677
New +$22.3K
KLTR icon
3597
Kaltura
KLTR
$247M
$40.1K ﹤0.01%
+20,864
New +$41K
CIG icon
3598
CEMIG Preferred Shares
CIG
$5.58B
$39.5K ﹤0.01%
+22,926
New +$36.6K
CMAX
3599
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$39.2K ﹤0.01%
+490
New +$57.3K
TJX icon
3600
CALL
TJX Companies
TJX
$169B
$39.2K ﹤0.01%
500
– –
142 143
144
145 146

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2023 Portfolio in Review

As of Q1 2023, Cubist Systematic Strategies held 4,854 positions worth $16.4B, down 4.4% from $17.1B the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.54B in Q1 2023, closing 1,012 positions and reducing 1,663 holdings. Its most notable exit was Graco, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Cubist Systematic Strategies opened a new position in Coterra Energy worth $14.3M.

  • Cubist Systematic Strategies's largest Q1 2023 buy was Coterra Energy: 582,419 shares worth $14.3M.
  • Cubist Systematic Strategies added most to Cigna in Q1 2023, an estimated $82.1M increase.
  • Cubist Systematic Strategies's biggest Q1 2023 reduction was Apple, cutting an estimated $73.1M.
  • Cubist Systematic Strategies fully exited Graco in Q1 2023, selling an estimated $21.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.7% of its $16.4B portfolio in Q1 2023.
  • Cubist Systematic Strategies opened 668 new positions and closed 1,012 in Q1 2023.
  • Cubist Systematic Strategies's portfolio value fell 4.4% quarter-over-quarter to $16.4B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.